BT-111

N/A

Report date: 2024/11/07 16:45:27
NME

Base Information

Drug NameBT-111
Drug Alias NameBT-111LABP-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanC-like protein 2 modulators
TargetsLanC-like protein 2
Therapy Area/IndicationsDiabetes Mellitus, Type 1Multiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLandos Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesLandos Biopharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Multiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A